Item 1.01. Entry into a Material Definitive Agreement.

On January 27, 2020, Navient Corporation (the "Company") completed a public offering of $700,000,000 aggregate principal amount of its 5.00% Senior Notes due 2027 (the "Notes").

The offering of the Notes was made pursuant to the Company's shelf registration statement on Form S-3 (Registration No. 333-218415) filed with the Securities and Exchange Commission (the "SEC") on June 1, 2017, including a related prospectus and prospectus supplement filed with the SEC on June 1, 2017 and January 23, 2020, respectively.

In connection with the offering of the Notes, the Company entered into an Underwriting Agreement, dated January 23, 2020 (the "Underwriting Agreement"), among the Company and RBC Capital Markets, LLC, BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters named therein (together, the "Underwriters"). Pursuant to the Underwriting Agreement, the Company agreed to sell the Notes to the Underwriters, and the Underwriters agreed to purchase the Notes for resale to the public. The Underwriting Agreement includes customary representations, warranties and covenants by the Company. It also provides for customary indemnification by each of the Company and the Underwriters against certain liabilities and customary contribution provisions in respect of those liabilities.

The Notes were issued under the base indenture, dated as of July 18, 2014 (the "Base Indenture"), between the Company and The Bank of New York Mellon, as trustee, as amended by an eleventh supplemental indenture, dated as of January 27, 2020 (the "Eleventh Supplemental Indenture," and together with the Base Indenture, the "Indenture").

The Underwriting Agreement, the Indenture and the form of global note for the offering are filed as exhibits to this Form 8-K and are incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an


           Off-Balance Sheet Arrangement of a Registrant.


The information related to the Indenture in Item 1.01 of this Form 8-K is hereby incorporated by reference into this Item 2.03.

Item 9.01(d). Financial Statements and Exhibits.

In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:



     •  should not in all instances be treated as categorical statements of fact,
        but rather as a way of allocating the risk to one of the parties if those
        statements prove to be inaccurate;


     •  may have been qualified by disclosures that were made to the other party
        in connection with the negotiation of the applicable agreement, which
        disclosures are not necessarily reflected in the agreement;


     •  may apply standards of materiality in a way that is different from what
        may be viewed as material to you or other investors; and


     •  were made only as of the date of the applicable agreement or such other
        date or dates as may be specified in the agreement and are subject to more
        recent developments.

--------------------------------------------------------------------------------

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about the Company may be found elsewhere in this report and the Company's other public filings, which are available without charge through the SEC's website at http://www.sec.gov.

--------------------------------------------------------------------------------


    Exhibit
      No.                                      Description

  Exhibit 1.1*         Underwriting Agreement, dated January 23, 2020, among the
                     Company and RBC Capital Markets, LLC, BofA Securities, Inc. and
                     J.P. Morgan Securities LLC, as representatives of the
                     Underwriters named therein.

  Exhibit 4.1          Indenture, dated as of July 18, 2014, between the Company and
                     The Bank of New York Mellon, as trustee (Incorporated by
                     reference to Exhibit 4.1 of the Company's Form S-3 filed on
                     July 18, 2014).

  Exhibit 4.2*         Eleventh Supplemental Indenture, dated as of January 27, 2020,
                     between the Company and The Bank of New York Mellon, as
                     trustee.

  Exhibit 4.3*         Form of Note for 5.00% Senior Notes due 2027 - included as
                     part of Exhibit 4.2 hereto.

  Exhibit 5.1*         Opinion of Skadden, Arps, Slate, Meagher & Flom LLP.

  Exhibit 23.1*        Consent of Skadden, Arps, Slate, Meagher & Flom LLP - included
                     as part of Exhibit 5.1 hereto.

  104                Cover Page Interactive Data File (embedded within the Inline
                     XBRL document).


* Filed herewith.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses